Insilico Medicine Cayman TopCo (3696) Stock Price & News

Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia

About Insilico Medicine Cayman TopCo

CEOFeng Ren | Alex Zhavoronkov

Employees333

Founded2014

Headquarters-

SectorHealth care

Websiteinsilico.com

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	14,39 m	14,39 m	53,15 m	53,15 m
Cost of goods sold	2,98 m	2,98 m	5,17 m	5,17 m
Cost of revenue	2,98 m	2,98 m	5,17 m	5,17 m
Research and development expenses	22,90 m	22,90 m	24,66 m	24,66 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7,05 m	7,05 m	9,47 m	9,47 m
Operating expense	30,23 m	30,23 m	33,85 m	33,85 m
Total operating expenses	33,20 m	33,20 m	39,02 m	39,02 m
Operating income	-18,81 m	-18,81 m	14,14 m	14,14 m
Other non operating income	-149,82 m	-149,82 m	1,50 k	1,50 k
EBT including unusual items	-166,54 m	-166,54 m	17,91 m	17,91 m
EBT excluding unusual items	-167,61 m	-167,61 m	16,57 m	16,57 m
Income tax expense	9,50 k	9,50 k	139,50 k	139,50 k
Effective tax rate	-0,01%	-0,01%	0,78%	0,78%
Other operating expenses	-	-	-	-
Net income	-166,55 m	-166,55 m	17,77 m	17,77 m
Net profit margin	-1 157,28%	-1 157,28%	33,43%	33,43%
Earnings per share	-	-	-	-
Interest and investment income	1,29 m	1,29 m	3,89 m	3,89 m
Interest expense	-56,00 k	-56,00 k	-83,00 k	-83,00 k
Net interest expenses	1,24 m	1,24 m	3,81 m	3,81 m
Depreciation and amortization charges	-	-	-	-
EBITDA	-18,08 m	-18,08 m	14,89 m	14,89 m
Gain or loss from assets sale	63,50 k	63,50 k	-	-

Finance

Ask anything